DrugPatentWatch Database Preview
Investigational Drug Information for Mibefradil
Email this page to a colleague
What is the development status for investigational drug Mibefradil?
Mibefradil is an investigational drug.
There have been 5 clinical trials for Mibefradil.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 28th 2018.
The most common disease conditions in clinical trials are Nervous System Neoplasms, Glioma, and Central Nervous System Neoplasms. The leading clinical trial sponsors are Cavion LLC, Jazz Pharmaceuticals, and LifeWatch Services, Inc.
There is one US patent protecting this investigational drug and eight international patents.
Summary for Mibefradil
| US Patents | 1,070 |
| International Patents | 8,528 |
| US Patent Applications | 4,108 |
| WIPO Patent Applications | 937 |
| Japanese Patent Applications | 931 |
| Clinical Trial Progress | Phase 1 (2018-05-28) |
| Vendors | 34 |
Recent Clinical Trials for Mibefradil
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population | Instituto Nacional de Salud Publica, Mexico | Phase 3 |
| Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population | Laboratorios Grossman, S.A. | Phase 3 |
| TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM | Yale University | Phase 1 |
Clinical Trial Summary for Mibefradil
Top disease conditions for Mibefradil
Top clinical trial sponsors for Mibefradil
US Patents for Mibefradil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Mibefradil | ⤷ Try it Free | Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof | The Regents of the University of California (Oakland, CA) | ⤷ Try it Free |
| Mibefradil | ⤷ Try it Free | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Mibefradil | ⤷ Try it Free | Synthetic linear apelin mimetics for the treatment of heart failure | NOVARTIS AG (Basel, CH) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Mibefradil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Mibefradil | European Patent Office | EP2981556 | 2033-04-02 | ⤷ Try it Free |
| Mibefradil | World Intellectual Property Organization (WIPO) | WO2014165513 | 2033-04-02 | ⤷ Try it Free |
| Mibefradil | Australia | AU2015210983 | 2034-01-30 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
